Literature DB >> 1299316

Beta-thalassaemia mutations and the underlying beta gene cluster haplotypes in the Greek population.

P Kollia1, P H Karababa, K Sinopoulou, E Voskaridou, M Boussiou, M Papadakis, D Loukopoulos.   

Abstract

The polymorphic sites across the beta gene cluster (restriction haplotypes) in association with specific thalassaemic mutations were analyzed in representative samples of normal and thalassaemic Greeks in comparison to similar data of other populations around the mediterranean basin. We studied 316 normal chromosomes, 218 chromosomes from patients with thalassaemia major and 72 chromosomes from patients with thalassaemia intermedia. In the former group, haplotype frequencies followed the order I, IX, II, V etc.. In the group of patients with transfusion-dependent thalassaemia the order was I, II, V and VI, while in those with thalassaemia intermedia the most frequent haplotypes were I and VI. The frequency of haplotypes I and VI was higher among the thalassaemic chromosomes in comparison to those of the normal population; haplotype IX showed the inverse relation. These findings imply that the thalassaemic mutations occurred at a very early stage on haplotypes I and VI and much later on haplotype IX. Micromapping did not reveal any significant variations. Haplotypes I, II, V and VI were associated with the molecular defects IVS-1 nt 110, beta zero-39, IVS-1 nt 1 and IVS-1 nt 6 respectively. A number of other mutations were also identified. The molecular defect was identified also on a random sample of beta-thalassaemia carriers (424 chromosomes). On the basis of the overall data, the feasibility of prenatal diagnosis of thalassaemia by allele specific hybridization is ca. 80%, with the four most common oligomers and 95% when the set of probes expands to eight.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1299316

Source DB:  PubMed          Journal:  Gene Geogr        ISSN: 0394-249X


  4 in total

1.  Scanning of beta-globin gene for identification of beta-thalassemia mutation in Romanian population.

Authors:  R Talmaci; J Traeger-Synodinos; E Kanavakis; D Coriu; D Colita; L Gavrila
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

2.  Humanized Mouse Model of Cooley's Anemia.

Authors:  Yongliang Huo; Sean C McConnell; Shan-Run Liu; Rui Yang; Ting-Ting Zhang; Chiao-Wang Sun; Li-Chen Wu; Thomas M Ryan
Journal:  J Biol Chem       Date:  2008-12-19       Impact factor: 5.157

3.  Preclinical transfusion-dependent humanized mouse model of beta thalassemia major.

Authors:  Yongliang Huo; Sean C McConnell; Thomas M Ryan
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

Review 4.  Haemoglobinopathies in Greece: prevention programme over the past 35 years.

Authors:  Dimitris Loukopoulos
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.